Sanara MedTech Inc. (SMTI): Price and Financial Metrics

Sanara MedTech Inc. (SMTI): $20.45

-0.06 (-0.29%)

POWR Rating

Component Grades














  • Sentiment is the dimension where SMTI ranks best; there it ranks ahead of 95.46% of US stocks.
  • SMTI's strongest trending metric is Quality; it's been moving down over the last 31 days.
  • SMTI ranks lowest in Momentum; there it ranks in the 16th percentile.

SMTI Stock Summary

  • SMTI's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 276.68 -- higher than 90.74% of US-listed equities with positive expected earnings growth.
  • The ratio of debt to operating expenses for Sanara MedTech Inc is higher than it is for about merely 6.87% of US stocks.
  • With a year-over-year growth in debt of -55.9%, Sanara MedTech Inc's debt growth rate surpasses only 6.19% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Sanara MedTech Inc, a group of peers worth examining would be GROW, SMID, IIIN, PGC, and ASPU.
  • Visit SMTI's SEC page to see the company's official filings. To visit the company's web site, go to

SMTI Growth Metrics

    Its year over year cash and equivalents growth rate is now at 579.4%.
  • Its 2 year net cashflow from operations growth rate is now at -2032.6%.
  • Its year over year revenue growth rate is now at 33.33%.
SMTI's revenue has moved up $16,061,810 over the prior 33 months.

The table below shows SMTI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 21.89965 -3.621237 -4.620099
2021-06-30 20.38203 -2.898222 -3.746955
2021-03-31 17.07208 -3.264103 -3.701227
2020-12-31 15.58698 -4.034518 -4.35644
2020-09-30 14.15093 -4.276972 -5.57307
2020-06-30 12.75389 -3.660028 -5.26282

SMTI Stock Price Chart Interactive Chart >

Price chart for SMTI

SMTI Price/Volume Stats

Current price $20.45 52-week high $43.89
Prev. close $20.51 52-week low $17.41
Day low $20.05 Volume 3,303
Day high $21.00 Avg. volume 17,046
50-day MA $22.31 Dividend yield N/A
200-day MA $27.28 Market Cap 163.15M

Sanara MedTech Inc. (SMTI) Company Bio

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

SMTI Latest News Stream

Event/Time News Detail
Loading, please wait...

SMTI Latest Social Stream

Loading social stream, please wait...

View Full SMTI Social Stream

Latest SMTI News From Around the Web

Below are the latest news stories about Sanara MedTech Inc that investors may wish to consider to help them evaluate SMTI as an investment opportunity.

Sanara MedTech: Technology For Faster Healing Wounds

Investment Thesis Sanara Medtech (SMTI) is a medical technology company that develops and commercializes products to improve chronic and surgical wounds and skin care. I believe SMTI provides a great investment opportunity for a growth-oriented investor because: 1. Addressable market for wound treatment is large ($28 B annual wound treatment...

Justin J. Lee on Seeking Alpha | December 8, 2021

Read More 'SMTI' Stories Here

SMTI Price Returns

1-mo N/A
3-mo -28.20%
6-mo -30.80%
1-year -44.22%
3-year 271.14%
5-year 162.18%
YTD -30.80%
2021 -40.78%
2020 209.94%
2019 392.35%
2018 -45.50%
2017 58.31%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6331 seconds.